Dr. Jordan Eric Axelrad, MD, MPH

Dr. Axelrad practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Axelrad's NPI, 1043585227, was assigned on March 20, 2012. Dr. Axelrad graduated from Tufts University School Of Medicine in 2012. Dr. Axelrad holds New York license 271009.

Dr. Axelrad's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Axelrad's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Axelrad is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Axelrad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Axelrad practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Axelrad's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Axelrad is licensed in New York.

CMS data shows 126 Medicare services from Dr. Axelrad across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $8,936 for them.

CMS counts 82 Medicare patients who saw Dr. Axelrad in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Axelrad's median patient age at 37, with 43% women.

In 2024, Dr. Axelrad wrote 329 Medicare Part D claims for 61 patients. 55% of them were for generic drugs. CMS names the drug for 204 of them, across 7 drugs with 11 or more claims each, at $2,327,330 in total drug cost. In 2023, CMS named 247 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Axelrad for performance year 2024, reported as part of a group. Dr. Axelrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Axelrad as offering telehealth. CMS counts 19 procedures of colonoscopy by Dr. Axelrad, more than 47% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 116 papers to Dr. Axelrad, published from 2012 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Inflammatory Bowel Diseases, Crohn Disease and Colitis, Ulcerative. Dr. Axelrad has published most often in Clin Gastroenterol Hepatol. Dr. Axelrad's most frequent co-authors are David Philip Hudesman, MD, Shannon Shung-Ling Chang, MD and Simon Jinwha Hong, MD.

Dmand AI links Dr. Axelrad to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Crohn Disease, Inflammatory Bowel Diseases and Clostridium Infections.

CMS Open Payments shows 319 general payments to Dr. Axelrad from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $58,018. It also lists 5 research payments totaling $1,822 from 2019 to 2024.

Dr. Axelrad graduated from Tufts University School Of Medicine in 2012.